94 related articles for article (PubMed ID: 19726317)
1. [Clinical value of (18)F-FDG positron emission tomography-computed tomography in local liver neoplasm ablation].
Liao WJ; Wu HB; Chen JZ; Shi M; You CX; Wang QS
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1641-2. PubMed ID: 19726317
[TBL] [Abstract][Full Text] [Related]
2. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
Wang XL; Li H; Wang QS; Zhang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890
[TBL] [Abstract][Full Text] [Related]
4. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
Sainani NI; Shyn PB; Tatli S; Morrison PR; Tuncali K; Silverman SG
J Vasc Interv Radiol; 2011 Mar; 22(3):354-60. PubMed ID: 21353987
[TBL] [Abstract][Full Text] [Related]
5. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
[TBL] [Abstract][Full Text] [Related]
6. Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT.
Vogt FM; Antoch G; Veit P; Freudenberg LS; Blechschmid N; Diersch O; Bockisch A; Barkhausen J; Kuehl H
J Nucl Med; 2007 Nov; 48(11):1836-44. PubMed ID: 17942811
[TBL] [Abstract][Full Text] [Related]
7. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
[TBL] [Abstract][Full Text] [Related]
8. Detection of residual tumor following radiofrequency ablation of liver metastases using 18F-FDG PET/PET-CT: a systematic review and meta-analysis.
Zheng JH; Chang ZH; Han CB; Ma JT; Liu ZY; Lu ZM; Guo QY
Nucl Med Commun; 2014 Apr; 35(4):339-46. PubMed ID: 24323312
[TBL] [Abstract][Full Text] [Related]
9. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
Shyn PB; Casadaban LC; Sainani NI; Sadow CA; Bunch PM; Levesque VM; Kim CK; Gerbaudo VH; Silverman SG
Radiology; 2018 Jul; 288(1):138-145. PubMed ID: 29613843
[TBL] [Abstract][Full Text] [Related]
10. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
11. Liver tumor F-18 FDG-PET before and immediately after microwave ablation enables imaging and quantification of tumor tissue contraction.
Yan Z; Khorasani R; Levesque VM; Gerbaudo VH; Shyn PB
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1618-1625. PubMed ID: 33175240
[TBL] [Abstract][Full Text] [Related]
12. Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results.
Travaini LL; Trifirò G; Ravasi L; Monfardini L; Della Vigna P; Bonomo G; Chiappa A; Mallia A; Ferrari M; Orsi F; Paganelli G
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1316-22. PubMed ID: 18338164
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
Langenhoff BS; Oyen WJ; Jager GJ; Strijk SP; Wobbes T; Corstens FH; Ruers TJ
J Clin Oncol; 2002 Nov; 20(22):4453-8. PubMed ID: 12431968
[TBL] [Abstract][Full Text] [Related]
14. Comparison of FDG-PET, MRI and CT for post radiofrequency ablation evaluation of hepatic tumors.
Chen W; Zhuang H; Cheng G; Torigian DA; Alavi A
Ann Nucl Med; 2013 Jan; 27(1):58-64. PubMed ID: 23054830
[TBL] [Abstract][Full Text] [Related]
15. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G
Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181
[TBL] [Abstract][Full Text] [Related]
16. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.
Casadaban LC; Catalano PJ; Lee LK; Hyun H; Tuncali K; Gerbaudo VH; Shyn PB
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2914-2924. PubMed ID: 33559712
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
18. PET/CT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20 s breath-hold PET acquisition.
Shyn PB; Tatli S; Sahni VA; Sadow CA; Forgione K; Mauri G; Morrison PR; Catalano PJ; Silverman SG
Clin Radiol; 2014 Apr; 69(4):410-5. PubMed ID: 24411824
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT in evaluation of radiofrequency ablation of liver metastasis.
Thulkar S; Chawla M; Sharma P; Malhotra A; Kumar R
Clin Nucl Med; 2012 May; 37(5):498-501. PubMed ID: 22475904
[TBL] [Abstract][Full Text] [Related]
20. Recurrent hepatic epithelioid hemangioendothelioma: detection by FDG PET/CT.
Lin E; Agoff N
Clin Nucl Med; 2007 Dec; 32(12):949-51. PubMed ID: 18030050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
